Quality of life and end-of-life issues for older patients with implanted cardiac rhythm devices
Related Experiment Video
Updated: May 17, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
1Department of Internal Medicine, Section of Cardiology, Yale University School of Medicine, 789 Howard Avenue, New Haven, CT 06510, USA. rachel.lampert@yale.edu
Abstract:
This article provides an overview of quality of life (QOL) and end-of-life issues that pertain to older patients with implanted cardiac rhythm devices. Most patients with implantable cardioverter-defibrillators (ICDs) enjoy similar QOL to that of other patients with cardiac diseases, especially in the absence of ICD shocks. Conventional pacemakers, as well as devices incorporating cardiac resynchronization, can improve QOL in appropriately selected patients regardless of age. In patients approaching the end of life, all devices, but especially ICDs, can adversely impact QOL in patients and families. All patients should have the opportunity to discuss the option of device deactivation.
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Dysrhythmias VII: Nursing Management of Dysrhythmias
Heart Failure VI: Adjunct Therapies
Ethical Issues
Ethical Concerns in Healthcare:
Cardiomyopathy II: Dilated Cardiomyopathy
Heart Failure VII: Nursing Interventions
